In:
DMW - Deutsche Medizinische Wochenschrift, Georg Thieme Verlag KG, Vol. 113, No. 13 ( 2018-07), p. 970-978
Abstract:
Chemotherapy-induced peripheral neuropathy (CIPN) is a severe and common side effect induced by a variety of anticancer drugs. CIPN presents as a sensory, motor, and sometimes autonomic dysfunction with a large variability, from a mild tingling sensation and hyperesthesia, to severe neuropathic pain. Up to 40 % of patients will develop CIPN which may lead to dose-reduction or discontinuation of their current treatment and largely affects their quality of life (QoL). This review presents specific clinical features and pathomechanisms and discusses current preventive strategies and therapeutic options.
Type of Medium:
Online Resource
ISSN:
0012-0472
,
1439-4413
DOI:
10.1055/s-0043-120839
Language:
German
Publisher:
Georg Thieme Verlag KG
Publication Date:
2018
detail.hit.zdb_id:
2035474-5
Permalink
